Treatment-free survival after discontinuation of immune checkpoint inhibitors in metastatic renal cell carcinoma: a systematic review and meta-analysis

• Alice Tzeng,
• Tony H Tzeng,
• Moshe C Ornstein

Affiliations

Alice Tzeng

Department of Medicine, Brigham and Women`s Hospital, Boston, Massachusetts, USA

Tony H Tzeng

School of Medicine, Louisiana State University Health Sciences Center, New Orleans, Louisiana, USA

Moshe C Ornstein

Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland, Ohio, USA